معرفی
Kishore Banik is a Researcher in the Department of Therapeutic Radiology at Yale School of Medicine, Yale University. He holds a PhD in Biosciences and Bioengineering/Cancer Biology from the Indian Institute of Technology Guwahati (2021) and an MSc in Biochemistry from the University of Pune (2013). His research focuses on cancer biology, drug discovery, and molecular mechanisms underlying tumor progression. He investigates the role of signaling pathways like Akt/mTOR, NF-κB, and STAT3 in cancer development, with a special emphasis on natural compounds such as curcumin, wogonin, and xanthohumol as potential chemosensitizers and anticancer agents.
Dr. Banik’s work explores strategies to enhance cancer therapy through targeted inhibition of PLK4, modulation of cytokine-induced proteins (e.g., TIPE family), and overcoming chemoresistance. His studies often integrate preclinical models and RNA sequencing to identify novel therapeutic targets. He is affiliated with the Hayman Lab, where he contributes to translational research aimed at bridging basic science and clinical applications.
His recent articles highlight advancements in understanding PLK4’s role in radiosensitivity, the antitumor effects of TNFAIP8 family proteins, and the bioavailability challenges of curcumin. While no formal awards are listed, his prolific publication record reflects sustained contributions to cancer research.
